Sentien (Drug Discovery) Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Out of Business

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Out of Business

Sentien (Drug Discovery) General Information

Description

Operator of a clinical-stage biotechnology company intended to treat patients suffering from a dysregulated immune system. The company helps to restore balance to the immune system and transform treatment options for patients with systemic inflammatory diseases and the blood conditioning approach has been proven to significantly enhance exposure, enabling patients to receive treatment for acute kidney injury and restoring balance to the immune system.

Contact Information

Website
www.sentienbiotech.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 99 Hayden Avenue
  • Building E, Suite 140
  • Lexington, MA 02421
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 99 Hayden Avenue
  • Building E, Suite 140
  • Lexington, MA 02421
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sentien (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Out of Business 29-Sep-2025 Completed Out of Business
11. Secondary Transaction - Private 15-Mar-2023 Completed Clinical Trials - Phase 2
10. Grant 20-Sep-2021 Completed Clinical Trials - Phase 1
9. Accelerator/Incubator 22-Jun-2020 Completed Clinical Trials - Phase 1
8. Debt - PPP 29-Apr-2020 Completed Clinical Trials - Phase 1
7. Later Stage VC (Series A) 28-Sep-2018 Completed Clinical Trials - Phase 1
6. Grant 01-Jan-2016 Completed Clinical Trials - Phase 1
5. Seed Round 12-Aug-2015 Completed Pre-Clinical Trials
4. Accelerator/Incubator Completed Pre-Clinical Trials
3. Grant 01-Jan-2014 $2.98M Completed Pre-Clinical Trials
To view Sentien (Drug Discovery)’s complete valuation and funding history, request access »

Sentien (Drug Discovery) Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A2
Series A1
Seed 564,562 $0.001000 8% $3.33 $3.33 1x $3.33 11.39%
To view Sentien (Drug Discovery)’s complete cap table history, request access »

Sentien (Drug Discovery) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical-stage biotechnology company intended to treat patients suffering from a dysregulated immune syste
Drug Discovery
Lexington, MA
10 As of 2024

Boston, MA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sentien (Drug Discovery) Competitors (47)

One of Sentien (Drug Discovery)’s 47 competitors is CervoMed, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CervoMed Formerly VC-backed Boston, MA
Neurona Therapeutics Formerly VC-backed South San Francisco, CA
T3D Therapeutics Venture Capital-Backed Durham, NC
Regenerative Medical Solutions Venture Capital-Backed Madison, WI
Cytokinetics Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 47 competitors. Get the full list »

Sentien (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Sentien (Drug Discovery) FAQs

  • When was Sentien (Drug Discovery) founded?

    Sentien (Drug Discovery) was founded in 2008.

  • Where is Sentien (Drug Discovery) headquartered?

    Sentien (Drug Discovery) is headquartered in Lexington, MA.

  • What is the size of Sentien (Drug Discovery)?

    Sentien (Drug Discovery) has 10 total employees.

  • What industry is Sentien (Drug Discovery) in?

    Sentien (Drug Discovery)’s primary industry is Drug Discovery.

  • Is Sentien (Drug Discovery) a private or public company?

    Sentien (Drug Discovery) is a Private company.

  • What is Sentien (Drug Discovery)’s current revenue?

    The current revenue for Sentien (Drug Discovery) is .

  • How much funding has Sentien (Drug Discovery) raised over time?

    Sentien (Drug Discovery) has raised $13.9M.

  • Who are Sentien (Drug Discovery)’s competitors?

    CervoMed, Neurona Therapeutics, T3D Therapeutics, Regenerative Medical Solutions, and Cytokinetics are some of the 47 competitors of Sentien (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process